Skip to main content

Save up to 20% on Elsevier print and eBooks with free shipping. No promo code needed.

Save up to 20% on print and eBooks.

Diabetes Digital Health, Telehealth, and Artificial Intelligence

1st Edition - July 1, 2024

Editors: David C. Klonoff, David Kerr, Juan Espinoza

Language: English
Paperback ISBN:
9 7 8 - 0 - 4 4 3 - 1 3 2 4 4 - 5
eBook ISBN:
9 7 8 - 0 - 4 4 3 - 1 3 2 4 3 - 8

Diabetes Digital Health, Telehealth, and Artificial Intelligence explains how to develop and use the emerging technologies of digital health, telehealth, and artificial intellige… Read more

Diabetes Digital Health, Telehealth, and Artificial Intelligence

Purchase options

LIMITED OFFER

Save 50% on book bundles

Immediately download your ebook while waiting for your print delivery. No promo code is needed.

Institutional subscription on ScienceDirect

Request a sales quote

Diabetes Digital Health, Telehealth, and Artificial Intelligence explains how to develop and use the emerging technologies of digital health, telehealth, and artificial intelligence to address this important public health problem to deliver new hardware, software, and processes. According to CDC, in the US there are 37 million people with diabetes and 96 million people with prediabetes. Diabetes triples the risk of myocardial infarction and stroke and is the leading cause of blindness, end stage renal failure, and amputations. The management of diabetes is becoming increasingly dominated by digital health tools consisting of wearable sensors, mobile applications providing decision support software, and wireless communication tools. Digital health provides new data streams that can be combined to create unique approaches for diabetes, based on a precision medicine paradigm.

Diabetes Digital Health, Telehealth, and Artificial Intelligence explore trends in developing and deploying the three most important emerging technologies for diabetes: digital health, telehealth, and artificial intelligence. This book is essential to clinicians, scientists, engineers, industry professionals, regulators, and investors offering the tools that will be used to create the next generation products to support a precision medicine approach to manage diabetes.